NCT00215150View on ClinicalTrials.gov

Geodon for the Treatment of Refractory Social Anxiety Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

July 31, 2009

Conditions
Social Anxiety Disorder
Interventions
DRUG

Ziprasidone

Sertraline augmentation with ziprasidone

DRUG

Sertraline

Treatment by sertraline in open label phase, followed by ziprasidone/placebo randomized augmentation in the randomized phase

Trial Locations (2)

27701

Duke University Medical Center, Durham

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Duke University

OTHER